The association between insurance status and prostate cancer outcomes: Implications for the Affordable Care Act

Prostate Cancer and Prostatic Diseases

Volumn 17, Issue 3, 2014, Pages 273-279

  Mahal, B A ^a   Aizer, A A ^b   Ziehr, D R ^a   Hyatt, A S ^a   Lago Hernandez, C ^a   Chen, Y W ^c   Choueiri, T K ^a   Hu, J C ^d   Sweeney, C J ^a   Beard, C J ^a   D'Amico, A V ^a   Martin, N E ^a   Trinh, Q D ^e   Nguyen, P L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UCLA MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EDUCATIONAL STATUS; HEALTH CARE POLICY; HEALTH INSURANCE ELIGIBILITY; HIGH RISK PATIENT; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; RURAL AREA; AGE; CANCER REGISTRY; ETHNOLOGY; HEALTH INSURANCE; HEALTH SURVEY; INCIDENCE; INSURANCE; MIDDLE AGED; MORTALITY; PROSTATIC NEOPLASMS; RISK FACTOR; UNITED STATES;

AGE FACTORS; HUMANS; INCIDENCE; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MIDDLE AGED; MORTALITY; PATIENT OUTCOME ASSESSMENT; PATIENT PROTECTION AND AFFORDABLE CARE ACT; POPULATION SURVEILLANCE; PROSTATIC NEOPLASMS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84906317369     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2014.23     Document Type: Article

References (45)

1. United States Census Bureau. Census 2000 Gateway. [online database] Available at http://www.census.gov/main/www/cen2000html. Accessed 27 December 2013.
2. Patient Protection and Affordable Care Act. Pub. L. No. 111-148, 114 Stat.119 (210
3. Sommers BD, Bindman AB. New physicians, the Affordable Care Act, and the changing practice of medicine. JAMA 2012; 307: 1697-1698.
4. Ferris LW, Farber M, Guidi TU, Laffey WJ. Impact of health care reform on the cancer patient: a view from cancer executives. Cancer J 2010; 16: 600-605.
5. Keegan KA, Penson DF. The Patient Protection and Affordable Care Act: the impact on urologic cancer care. Urol Oncol 2013; 31: 980-984.
6. Albright HW, Moreno M, Feeley TW, Walter R, Samuels M, Pereira A et al. The implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on cancer care delivery. Cancer 2011; 117: 1564-1574.
7. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
8. SEER Cancer Statistics Review, 1975-2010National Cancer Institute: Bethesda, MDhttp://seer.cancer.gov/csr/1975-2010/based on November 2012 SEER data submission, posted to the SEER website, 2013.
9. Surveillance, Epidemiology, and End Results (SEER) Program. Research Data (1973-2010), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, based on November 2012 SEER data submission, posted to the SEER website 2013. www.seer.cancer.gov.
10. NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer 2014. Available at http://www.nccn.org. Accessed 30 December 2013.
11. United States Department of Agriculture Rural-Urban Continuum Codes. [online database] Available at http://www.ers.usda.gov/data-products/rural- urban-continuum-codes.aspx. Accessed 27 December 2013.
12. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML. Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy. J Urol 2008; 179: 1354-1360.
13. Cox DR. Regression models and life-tables. J R Stat Soc B 1972; 34: 187-220.
14. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
15. Shen JJ, Washington EL. Disparities in outcomes among patients with stroke associated with insurance status. Stroke 2007; 38: 1010-1016.
16. Glueckert LN, Redden D, Thompson MA, Haque A, Gray SH, Locke J et al. What liver transplant outcomes can be expected in the uninsured who become insured via the Affordable Care Act? Am J Transplant 2013; 13: 1533-1540.
17. Hasan O, Orav EJ, Hicks LS. Insurance status and hospital care for myocardial infarction, stroke, and pneumonia. J Hosp Med 2010; 5: 452-459.
18. Shi L, Lebrun LA, Zhu J, Tsai J. Cancer screening among racial/ethnic and insurance groups in the United States: a comparison of disparities in 2000 and 2008. J Health Care Poor Underserved 2011; 22: 945-961.
19. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 1993; 329: 326-331.
20. Trinh QD, Schmitges J, Sun M, Sammon J, Shariat SF, Zorn K et al. Morbidity and mortality of radical prostatectomy differs by insurance status. Cancer 2012; 118: 1803-1810.
21. Kelz RR, Gimotty PA, Polsky D, Norman S, Fraker D, DeMichele A. Morbidity and mortality of colorectal carcinoma surgery differs by insurance status. Cancer 2004; 101: 2187-2194.
22. Brookfield KF, Cheung MC, Lucci J, Fleming LE, Koniaris LG. Disparities in survival among women with invasive cervical cancer: a problem of access to care. Cancer 2009; 115: 166-178.
23. Dasenbrock HH, Wolinsky JP, Sciubba DM, Witham TF, Gokaslan ZL, Bydon A. The impact of insurance status on outcomes after surgery for spinal metastases. Cancer 2012; 118: 4833-4841.
24. Fedewa SA, Etzioni R, Flanders WD, Jemal A, Ward EM. Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006. Cancer Epidemiol Biomarkers Prev 2010; 19: 2437-2444.
25. Sadetsky N, Lubeck DP, Pasta DJ, Latini DM, DuChane J, Carroll PR. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor. BJU Int 2008; 101: 691-697.
26. Gallina A, Karakiewicz P, Chunk FK, Briganti A, Graefen M, Montorsi F et al. Healthinsurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer. BJU Int 2007; 99: 1404-1408.
27. Penson DF, Stoddard ML, Pasta DJ, Lubeck DP, Flanders SC, Litwin MS. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epidemiol 2001; 54: 350-358.
28. Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999; 91: 1409-1415.
29. Niu X, Roche LM, Pawlish KS, Henry KA. Cancer survival disparities by health insurance status. Cancer Med 2013; 2: 403-411.
30. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004; 22: 2141-2149.
31. Miller DC, Litwin MS, Bergman J, Stepanian S, Connor SE, Kwan L et al. Prostate cancer severity among low income, uninsured men. J Urol 2009; 181: 579-583.
32. Brown ER, Davidson PL, Yu H, Wyn R, Andersen RM, Becerra L et al. Effects of community factors on access to ambulatory care for lower-income adults in large urban communities. Inquiry 2004; 41: 39-56.
33. Stein JA, Andersen RM, Gelberg L. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res 2000; 34: 1273-1302.
34. Miller DC, Gelberg L, Kwan L, Stepanian S, Fink A, Andersen RM et al. Racial disparities in access to care for men in a public assistance program for men in a public assistance program for prostate cancer. J Community Health 2008; 33: 318-335.
35. Andersen RM, Yu H, Wyn R, Davidson PL, Brown ER, Teleki S. Access to medical care for low-income persons: how do communities make a difference? Med Care Res Rev 2002; 59: 384-411.
36. Underwood W, De Monner S, Ubel P, Fagerlin A, Sanda MG, Wei JT. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol 2004; 171: 1504-1507.
37. Presley CJ, Raldow AC, Cramer LD, Soulos PR, Long JB, Yu JB et al. A new approach to understanding racial disparities in prostate cancer treatment. J Geriatr Oncol 2013; 4: 1-8.
38. Hamilton AS, Fleming ST, Wang D, Goodman M, Wu XC, Owen JB et al. Clinical and demographic factors associated with receipt of non guideline-concordant initial therapy for nonmetastatic prostate cancer. Am J Clin Oncol 2014, e-pub ahead of print (Accessed 1 February 2014
39. Stokes WA, Hendrix LH, Royce TJ, Allen IM, Godley PA, Wang AZ et al. Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study. Cancer 2013; 119: 2486-2493.
40. Tewari AK, Gold HT, Demers RY, Johnson CC, Yadav R, Wagner EH et al. Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology 2009; 73: 624-630.
41. Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Sammon JD, Schmid M et al. The influence of insurance status on racial disparities in the treatment of African-American men with high-risk prostate cancer. Urol Oncol 2014, e-pub ahead of print (Accessed 1 May 2014
42. Steelfisher GK, Blendon RJ, Sussman T, Connolly JM, Benson JM, Herrmann MJ. Physicians' views of the Massachusetts Health Care Reform Law-A poll. N Engl J Med 2009; 361: e39.
43. Staiger DO, Auerbach DI, Buerhaus PI. Health care reform and the health care workforce-the Massachusetts experience. N Engl J Med 2011; 365: e24.
44. Wilensky GR. The shortfalls of 'Obamacare'. N Engl J Med 2012; 367: 1479-1481.
45. Moyer VA. Screening for prostate cancer: U.S. Preventative Services Task Force recommendation statement. Ann Intern Med 2012; 157: 120-134.